Suchergebnisse - "Viciana, Pompeyo"

PubPharm (185)

1

Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017 : Implementation of a Screening Program

enthalten in: Diseases of the colon and rectum | 2022

von Milanés Guisado, Y. | Sotomayor, C. | Fontillón, M. | +7

CommentIn: Dis Colon Rectum. 2022 Jan 1;65(1):1-3. - PMID 34694280

2

Mesenchymal stromal cells in human immunodeficiency virus-infected patients with discordant immune response : Early results of a phase I/II clinical trial

enthalten in: Stem cells translational medicine | 2021

von Trujillo-Rodríguez, M. | Viciana, P. | Rivas-Jeremías, I. | +10

3

Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response : Early results of a phase I/II clinical trial

enthalten in: Stem cells translational medicine | 2021

von Trujillo‐Rodríguez, M. | Viciana, P. | Rivas‐Jeremías, I. | +10

4

Persistent HIV-controllers are more prone to spontaneously clear HCV : a retrospective cohort study

enthalten in: Journal of the International AIDS Society | 2020

von Dominguez-Molina, B. | Tarancon-Diez, L. | Milanés-Guisado, Y. | +17

5

Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus

enthalten in: Antimicrobial agents and chemotherapy | 2020

von De Pablo-Bernal, R. | Jimenez-Leon, M. | Tarancon-Diez, L. | +10

6

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS : a prospective multicentre cohort study

enthalten in: The lancet. HIV | 2020

von Serrano-Villar, S. | Martínez-Sanz, J. | Ron, R. | +112

CommentIn: Lancet HIV. 2020 Aug;7(8):e526-e527. - PMID 32763212

7

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice : a multicentre cohort study

enthalten in: AIDS research and therapy | 2020

von Suárez-García, I. | Moreno, C. | Ruiz-Algueró, M. | +110

8

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

enthalten in: AIDS research and therapy | 2020

von Suárez-García, I. | Moreno, C. | Ruiz-Algueró, M. | +9

9

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

enthalten in: AIDS research and therapy | 2020

von Suárez-García, I. | Moreno, C. | Ruiz-Algueró, M. | +9

10

Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Milanés-Guisado, Y. | Gutiérrez-Valencia, A. | Muñoz-Pichardo, J. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]